MedTrace Logo

The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)

NCT00892554 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2015-12-11

No results posted yet for this study

Summary

The purpose of this study is to determine if taking supplemental DHA improves measures of processing speed and executive function in teen and adult women with PKU.

Conditions

Interventions

DIETARY_SUPPLEMENT

Docosahexaenoic Acid

Capsules providing 10 mg DHA/kg body weight/day taken once daily

DIETARY_SUPPLEMENT

Corn/soy oil

Capsules taken once daily

Sponsors & Collaborators

  • Atlanta Clinical and Translational Science Institute

    collaborator OTHER

  • Emory University

    lead OTHER

Principal Investigators

  • Rani H. Singh, PhD, RD, LD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00892554 on ClinicalTrials.gov